Aging, mild cognitive impairment, and Alzheimer's disease

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Research in the field of aging and dementia is moving forward at a rapid pace, in both basic biology of dementing disorders and clinical investigations. These two approaches to research on aging and dementia need to advance in parallel, such that when work on the pathophysiology of these disorders is translated into therapeutic practice, the appropriately characterized clinical cohorts will be available for therapeutic trials of these treatment strategies. Significant challenges remain. The course of cognition in normal aging needs to be characterized. Clinical cohorts need to be assembled and followed longitudinally to allow investigators to study normal aging and the earliest transition into impairment. The role of neuroimaging must be clarified and biomarkers of disease must be developed. Much work remains to be done, but if the progress of the previous decade has been indicative of the future, the outlook is bright.

Original languageEnglish (US)
Pages (from-to)789-805
Number of pages17
JournalNeurologic Clinics
Volume18
Issue number4
DOIs
StatePublished - 2000

Fingerprint

Dementia
Alzheimer Disease
Research
Neuroimaging
Cognition
Biomarkers
Research Personnel
Therapeutics
Cognitive Dysfunction

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Aging, mild cognitive impairment, and Alzheimer's disease. / Petersen, Ronald Carl.

In: Neurologic Clinics, Vol. 18, No. 4, 2000, p. 789-805.

Research output: Contribution to journalArticle

@article{f437880f4de14f81bbe70aaa13667c33,
title = "Aging, mild cognitive impairment, and Alzheimer's disease",
abstract = "Research in the field of aging and dementia is moving forward at a rapid pace, in both basic biology of dementing disorders and clinical investigations. These two approaches to research on aging and dementia need to advance in parallel, such that when work on the pathophysiology of these disorders is translated into therapeutic practice, the appropriately characterized clinical cohorts will be available for therapeutic trials of these treatment strategies. Significant challenges remain. The course of cognition in normal aging needs to be characterized. Clinical cohorts need to be assembled and followed longitudinally to allow investigators to study normal aging and the earliest transition into impairment. The role of neuroimaging must be clarified and biomarkers of disease must be developed. Much work remains to be done, but if the progress of the previous decade has been indicative of the future, the outlook is bright.",
author = "Petersen, {Ronald Carl}",
year = "2000",
doi = "10.1016/S0733-8619(05)70226-7",
language = "English (US)",
volume = "18",
pages = "789--805",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Aging, mild cognitive impairment, and Alzheimer's disease

AU - Petersen, Ronald Carl

PY - 2000

Y1 - 2000

N2 - Research in the field of aging and dementia is moving forward at a rapid pace, in both basic biology of dementing disorders and clinical investigations. These two approaches to research on aging and dementia need to advance in parallel, such that when work on the pathophysiology of these disorders is translated into therapeutic practice, the appropriately characterized clinical cohorts will be available for therapeutic trials of these treatment strategies. Significant challenges remain. The course of cognition in normal aging needs to be characterized. Clinical cohorts need to be assembled and followed longitudinally to allow investigators to study normal aging and the earliest transition into impairment. The role of neuroimaging must be clarified and biomarkers of disease must be developed. Much work remains to be done, but if the progress of the previous decade has been indicative of the future, the outlook is bright.

AB - Research in the field of aging and dementia is moving forward at a rapid pace, in both basic biology of dementing disorders and clinical investigations. These two approaches to research on aging and dementia need to advance in parallel, such that when work on the pathophysiology of these disorders is translated into therapeutic practice, the appropriately characterized clinical cohorts will be available for therapeutic trials of these treatment strategies. Significant challenges remain. The course of cognition in normal aging needs to be characterized. Clinical cohorts need to be assembled and followed longitudinally to allow investigators to study normal aging and the earliest transition into impairment. The role of neuroimaging must be clarified and biomarkers of disease must be developed. Much work remains to be done, but if the progress of the previous decade has been indicative of the future, the outlook is bright.

UR - http://www.scopus.com/inward/record.url?scp=0034525923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034525923&partnerID=8YFLogxK

U2 - 10.1016/S0733-8619(05)70226-7

DO - 10.1016/S0733-8619(05)70226-7

M3 - Article

C2 - 11072261

AN - SCOPUS:0034525923

VL - 18

SP - 789

EP - 805

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 4

ER -